PATENT CLAIM ANALYSIS

Application Number: 16042917
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["435", "366000"]

Abstract:
Disclosed herein are methods, compositions, kits, and agents useful for inducing β cell maturation, and isolated populations of SC-β cells for use in various applications, such as cell therapy.

Claim (Index 17):
The device of  claim 14 , wherein the non-native pancreatic \u03b2 cells are separated by the semipermeable membrane in an islet chamber from one or more vascularizing chamber of the device.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.25
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14684101', '14975158', '15478094', '14670249', '12167227']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6411303044529214
- 35 USC 102 Novelty (BERT): 0.5941783796914548
- Combined Prediction Score: 0.6364351119767747
- Mean Citation Score: 422.614236
- Max Citation Score: 630.4137599999998
- Similarity Product: 418.8984066119955

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test